Search results
Results from the WOW.Com Content Network
Pirenoxine (abbreviated PRX, trade name Catalin) is a medication used in the possible treatment and prevention of cataracts. A report in the Inorganic Chemistry journal s howed that in liquid solutions, pirenoxine could cause decreased cloudiness of a crystallin solution produced to mimic the environment of the eye.
Prevalence of cataract considerably varies by age group, as well: for ages 50–59, it is 7.88%; for ages 60–69, it is 24.94%; for ages 70–79, it is 51.74%; in people over 80 years old, it is 78.43%. The overall cataract-surgery coverage rate was 9.19%. The prevalence of cataract and cataract surgical coverage also significantly varies by ...
Cataract surgery is the removal of the natural lens of the eye that has developed a cataract, an opaque or cloudy area. [3] Over time, metabolic changes of the crystalline lens fibres lead to the development of a cataract, causing impairment or loss of vision.
Commonly, a patient with small congenital cataracts that do not damage vision will be affected later in life, though this will take decades to occur. [ 135 ] As of 2015 [update] , the standard of care for pediatric cataract surgery for children older than two years is primary posterior intraocular lens (IOL) implantation.
Life expectancy by world region, from 1770 to 2018. This is a list of countries showing past life expectancy, ranging from 1950 to 2015 in five-year periods, as estimated by the 2017 revision of the World Population Prospects database by the United Nations Population Division. Life expectancy equals the average number of years a person born in ...
John Harnett Noseworthy (born 9 November 1951) is an American neurologist who served as the president and chief executive officer of Mayo Clinic from 2009 to 2018. A board-certified neurologist specializing in multiple sclerosis, Noseworthy is the former editor-in-chief of Neurology, the official journal of the American Academy of Neurology. [1]
Diabetic retinopathy (also known as diabetic eye disease) is a medical condition in which damage occurs to the retina due to diabetes.It is a leading cause of blindness in developed countries and one of the lead causes of sight loss in the world, even though there are many new therapies and improved treatments for helping people live with diabetes.
A Hollenhorst plaque (also known as a retinal cholesterol embolus) is a cholesterol embolus that is seen in a blood vessel of the retina.It is usually found when a physician performs ophthalmoscopy, during which a plaque will appear as a small, bright crystal that is refractile (reflects the light from the ophthalmoscope) and yellow. [1]